NASDAQ:COGT
Cogent Biosciences, Inc.
- Stock
Last Close
9.22
26/07 20:00
Market Cap
851.92M
Beta: −0.40
Volume Today
417.71K
Avg: 610.94K
PE Ratio
−2.90
PFCF: −4.64
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -6.59M - | -18.12M 174.94% | -25.49M 40.65% | -34.53M 35.46% | -31.83M 7.82% | -74.81M 135.00% | -72.27M 3.39% | -140.24M 94.04% | -192.41M 37.20% | |
depreciation and amortization | 179K - | 830K 363.69% | 1.17M 41.08% | 1.32M 12.81% | 1.29M 2.12% | 720K 44.32% | 147K 79.58% | 5.88M 3,898.64% | 3.59M 38.96% | |
deferred income tax | -248K - | 17K 106.85% | 17K 0% | -236K 1,488.24% | -7.49M - | -4.81M - | ||||
stock based compensation | 248K - | 1.02M 309.68% | 1.34M 31.99% | 3.09M 130.28% | 3.24M 4.95% | 6.02M 85.65% | 11.69M 94.22% | 18.37M 57.18% | 30.62M 66.71% | |
change in working capital | 23.88M - | -2.32M 109.73% | -2.88M 23.93% | -2.15M 25.22% | -14.08M 554.16% | -5.32M 62.26% | 2.02M 138.00% | 751K 62.82% | 11.44M 1,423.57% | |
accounts receivables | -294K - | -634K 115.65% | 98K 115.46% | -838K 955.10% | -332K 60.38% | 2M 702.41% | ||||
inventory | 220K - | 784K 256.36% | 931K 18.75% | 2.21M 137.81% | 1.22M 44.99% | -3.55M 391.46% | ||||
accounts payables | 705K - | 389K 44.82% | -31K 107.97% | 367K 1,283.87% | 1.66M 353.41% | -2.45M 247.30% | 2.75M 212.24% | 2.36M 14.25% | 4.81M 104.03% | |
other working capital | 23.25M - | -2.86M 112.31% | -3.88M 35.46% | -3.90M 0.49% | -16.63M 326.95% | -1.31M 92.09% | -731K 44.41% | -1.61M 119.97% | -4.81M 199.32% | |
other non cash items | 248K - | -56K 122.58% | 7K 112.50% | 23K 228.57% | -131K 669.57% | 45.03M 34,474.05% | -343K 100.76% | -3.39M 889.50% | -2.05M 39.54% | |
net cash provided by operating activities | 17.72M - | -18.64M 205.22% | -25.84M 38.60% | -32.49M 25.76% | -41.51M 27.78% | -35.85M 13.64% | -58.76M 63.91% | -118.64M 101.89% | -153.62M 29.49% | |
investments in property plant and equipment | -1.99M - | -3.31M 65.85% | -912K 72.42% | -549K 39.80% | -33K 93.99% | -1.72M - | -6.86M 299.24% | -2.80M 59.26% | ||
acquisitions net | 204K - | 8.42M 4,027.45% | 117.86K - | |||||||
purchases of investments | -55.17M - | -6.50M 88.22% | -47.68M 633.57% | -204K 99.57% | -177.85M - | -348.80M 96.12% | ||||
sales maturities of investments | 28M - | 21M 25% | 37.70M 79.52% | 22.99M 39.02% | 60M - | 253.78M 322.96% | ||||
other investing activites | -1.25M - | 50K 103.98% | -75K 250% | 204K - | -117.86K - | |||||
net cash used for investing activites | -3.25M - | -30.43M 836.57% | 13.51M 144.41% | -10.53M 177.93% | 23.16M 319.91% | 8.42M 63.64% | -1.72M 120.42% | -124.72M 7,155.26% | -97.82M 21.56% | |
debt repayment | ||||||||||
common stock issued | 60K - | 71.79M 119,555% | 108K 99.85% | 132.73M 122,797.22% | 38.01M 71.37% | 161.94M 326.10% | 161.82M 0.08% | |||
common stock repurchased | ||||||||||
dividends paid | ||||||||||
other financing activites | 70.75M - | -40K 100.06% | -789K 1,872.50% | -1.45M 83.40% | 108 100.01% | 99.47M 92,098,974.07% | -30K 100.03% | 1.61M 5,476.67% | 1.72M 6.45% | |
net cash used provided by financing activities | 70.75M - | -40K 100.06% | -729K 1,722.50% | 70.35M 9,749.66% | 108K 99.85% | 232.20M 214,896.30% | 37.98M 83.64% | 163.56M 330.69% | 163.54M 0.01% | |
effect of forex changes on cash | ||||||||||
net change in cash | 85.22M - | -49.11M 157.63% | -13.05M 73.42% | 27.33M 309.38% | -18.25M 166.78% | 204.77M 1,222.19% | -22.51M 110.99% | -79.80M 254.56% | -87.91M 10.17% | |
cash at beginning of period | 5.21M - | 90.43M 1,635.37% | 41.32M 54.31% | 29.60M 28.37% | 56.93M 92.32% | 38.68M 32.05% | 243.44M 529.40% | 220.94M 9.24% | 141.14M 36.12% | |
cash at end of period | 90.43M - | 41.32M 54.31% | 28.27M 31.58% | 56.93M 101.37% | 38.68M 32.05% | 243.44M 529.40% | 220.94M 9.24% | 141.14M 36.12% | 53.23M 62.29% | |
operating cash flow | 17.72M - | -18.64M 205.22% | -25.84M 38.60% | -32.49M 25.76% | -41.51M 27.78% | -35.85M 13.64% | -58.76M 63.91% | -118.64M 101.89% | -153.62M 29.49% | |
capital expenditure | -1.99M - | -3.31M 65.85% | -912K 72.42% | -549K 39.80% | -33K 93.99% | -1.72M - | -6.86M 299.24% | -2.80M 59.26% | ||
free cash flow | 15.72M - | -21.95M 239.59% | -26.75M 21.87% | -33.04M 23.52% | -41.55M 25.76% | -35.85M 13.71% | -60.48M 68.71% | -125.50M 107.50% | -156.42M 24.64% |
All numbers in USD (except ratios and percentages)